Eficacia y Seguridad a largo plazo de upadacitinib o adalimumab en pacientes con artritis reumatoide: resultados a lo largo de 3 años del estudio SELECT-COMPARE
RMD Open. 2022;8(1):e002012 doi: 10.1136/rmdopen-2021-002012
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
RMD Open. 2022;8(1):e002012 doi: 10.1136/rmdopen-2021-002012
Rheumatology (Oxford). 2021. Epub ahead of print. doi: 10.1093/rheumatology/keab861
Ann Rheum Dis. 2021. Epub ahead of print. doi: 10.1136/annrheumdis-2021-221276.
J Rheumatol. 2021 Sep 15:jrheum.210346.
Arthritis Res Ther 2021;23(1):3.
Arthritis Rheumatol 2019 DOI: 10.1002/art.41032
Clinical Rheumatology 2018;37:2381–90 DOI 10.1007/s10067-018-4221-0
Arthritis Res Ther. 2017 Sep 18;19(1):208